Introduction
ensued. Antibiotics and anti-inflammatory drugs were administered, but the pain increased, with development of a palpable mass. Ultrasonography revealed an abscess-like lesion, with enlarged lymph nodes under the left axilla. She was admitted to a surgery unit where surgical debridement and drainage were performed. Neither common bacteria nor atypical and/or neoplastic cells were identified; only a thick lymphocytic infiltrate remained, compatible with unspecific inflammation. She was discharged with the diagnosis of a post-traumatic abscess, continuing on antibiotics. After a few days, the breast swelling returned and the skin developed an orange peel-like appearance. A fistula appeared, opening in the medial (inner) upper quadrant of the left breast. The patient returned to the same surgery unit. She had never undergone a mammography; the surgeons decided to immediately obtain multiple biopsies from the fistula, the mammary tissue, and the axillary lymph nodes. A granulomatous necrotizing tissue reaction with giant cells was identified; so she was referred to our hospital for further investigations. A chest radiogram revealed an irregular opacity of the left upper lobe in the left lung, confirmed by high-resolution computed tomography (HRCT), with ground-glass appearance, surrounding the lesion and with involvement of subcutaneous tissues ( fig. 1 ). No rib involvement was detected. A magnetic resonance imaging (MRI) scan with gadolinium better defined the presence of 2 distinct communicating abscesses, one on the inner side of the muscular chest wall and the other in the center of the mammary tissue, with cutaneous fistulization; furthermore, 2 other fistulae reaching through the mammary tissue were revealed ( fig. 2) . Notably no cough and/or sputum were present. The search for mycobacterium tuberculosis complex (MTC) members on a bronchoscopic aspiration probe resulted negative, but examination of the secretion of the fistula revealed the presence of MTC by microscopy; GeneXpert ® analysis did not reveal resistance to rifampicin. Treatment with rifampicin, isoniazid, pyrazinamide, and ethambutol was started, and the patient was discharged in good clinical condition, with marked improvement of the breast lesions just after a few weeks. Later, an antibiogram revealed resistance to isoniazid; so this drug was interrupted and replaced by levofloxacin -streptomycin was excluded due to the patient's difficulty to perform intramuscular therapy. At the 9-month visit of follow-up, she was well and the therapy was interrupted.
Discussion
TB should always be considered in the first evaluation of a breast lesion, also in Western countries. Furthermore, considering risk factors, our patient was rather far advanced through the years of her reproductive age and was, of course, not lactating, but she comes from a high-TB burden country such as the Ukraine. It is then mandatory to perform an accurate clinical and radiological examination of the chest, even in the absence of pulmonary symptoms.
Mammary TB was described in 1829 [7] : A primary involvement occasionally exists [8, 9] , whereas secondary forms are less uncommon [10] . Considering lung involvement, this patient constitutes a case of secondary breast TB. McKeown and Wilkinson [11] classified 5 different types of breast TB: (1) nodular tubercular mastitis, (2) disseminated or confluent tubercular mastitis, (3) sclerosing tubercular mastitis, (4) tuberculous mastitis obliterans, and (5) acute miliary tubercular mastitis. The pathways of MTC spreading to the breast are by hematogenic route, by lymphatic routes from the axillary, mediastinal, or cervical lymph nodes, or directly from underlying structures such as the ribs or pleura, or by the inoculation of infected sputum. Our patient presented a confluent tubercular mastitis; propagation through lymphatic structures is the most probable way of diffusion of MTC in this case.
The role of the chest trauma -coincidental or not -remains to be clarified. Since initial reports [12] , trauma has been proposed as a possible risk factor for breast TB; damaged tissue may constitute an area of lessened resistfgance. Cases of extra-pulmonary TB were reported in sites of previous non-penetrating trauma [13] . For pathogenesis, other mechanisms have also been proposed, involving the transport of MTC by monocytes to sites of injury, opening new spaces for future research.
We want to stress the link, at least a temporal one, between surgical maneuvers and the diagnosis of pulmonary TB. There was no X-ray of the chest that could have resulted in a breast abscess, nor were there clinical symptoms or signs to determine the exact period of the insurgence of lung involvement, and the hypothesis of a primary breast TB cannot be sustained with absolute certainty. In the past, a correlation has been reported between the reactivation of pulmonary TB and gastrectomy [14, 15] ; the pathogenesis remained speculative. Cases of extra-pulmonary TB reactivation after surgery of the hip have been reported [16, 17] . To our knowledge, no cases have been described of pulmonary TB reactivation just after surgery and/or invasive procedures on the chest; it is, however, plausible that repeated minor and major surgical procedures, with the reactivation of a latent infection, may have facilitated local MTC diffusion.
Other infective agents, e.g. non-tubercular mycobacteria, could induce mammary lesions, sometimes just after a trauma [18, 19] . An idiopathic granulomatous mastitis has been described as a rare benign inflammatory breast disease that is frequently mistaken for breast carcinoma [20] ; its etiology is unknown, but some cases have been associated with previous breast trauma [21] .
Of course, in the face of breast lesions involving the chest wall, it is mandatory to rule out cancer. Moreover, TB and cancer may coexist [22] .
In fact, some data (absence of response to antibiotics, HRCT evidence of solid lesions in the left lung without significant infectious symptoms, appearance of orange peel-like skin followed by fistulization) could hint at a potential cancer. Notably, neither mammography nor fine-needle ago-biopsy (FNAB) was performed. In turn, an FNAB should always be performed when suspecting breast cancer [23] . Furthermore, the great potential of MRI scans in defining breast lesions has to be stressed [24] . By MRI, we obtained a better definition of the extension of the abscesses and fistulae through the tissue, which CT did not show as well. MRI can be a good tool in every case of a doubtful breast lesion, as it is a non-invasive tool and -especially in young women -it is free from collateral effects due to radiation.
However, breast tissue remains usually resistant to MTC: By 1982, only 500 cases were collected by examining the entire world literature [25] , and till 1987, less than 100 cases were reported from India [26] . Most of the cases described until today have occurred in India, with a global incidence of less of 4.5% of the totality of the mammary pathologies [27] . The best way to make a diagnosis remains by considering the following: difficulties encountered in excluding pyogenic abscesses or neoplasms. To our knowledge, this is the first case of pulmonary TB with breast involvement reported after a trauma. We can refer our samples to highly qualified histologic and microbiologic laboratories, which immediately perform GeneXpert analyses on positive samples to identify MTC and resistance to rifampicin, and then make an antibiogram to test resistances to major anti-mycobacterial drugs, such as isoniazid in this case. This approach is critical for our diagnostic and therapeutic successes.
Conclusions
Clinical awareness of TB is always necessary in evaluating breast lesions. Trauma could be a potential risk factor for the reactivation of a latent tubercular infection, and this link may disclose new mechanisms of MTC diffusion. Nuclear MRI is a non-invasive tool to obtain breast images with optimal definition; however, FNAB should be performed in every case of uncertain origin. Qualified microbiologic and histologic laboratories are essential for successful diagnostic and therapeutic processes.
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